BIOLIT ApS: Financial statements 2020
CVR: 10068460
Source: annual report 2020, Danish Business Authority
01/06/2019 – 31/05/2020
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,529,689 and a net result of DKK 1,736,745 compared with DKK 1,475,787 the year before. That is a decrease of 22.2% compared with the year before. Equity in the 2020 report amounted to DKK 8,818,653. The solvency ratio was 59.3%.
- Gross Profit
- DKK 1,529,689
- Profit/Loss
- DKK 1,736,745
- Equity
- DKK 8,818,653
- Total Assets
- DKK 14,880,522
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.5 mio. | 1.7 mio. | 8.8 mio. | - |
| 2019 | - | 2 mio. | 1.5 mio. | 7.1 mio. | - |
| 2018 | - | 1.3 mio. | 954 t. | 5.6 mio. | - |
| 2017 | - | 1.4 mio. | 1.1 mio. | 4.7 mio. | - |
| 2016 | - | 1.8 mio. | 1.4 mio. | 3.6 mio. | - |
How creditworthy is BIOLIT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees (2006). In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity in the 2025 report amounted to DKK 10,762,624.